CI monthly performance report
Explore CI's monthly returns, drawdown, and seasonality trends — updated every month.
CI monthly report
—
Key takeaways
- Cigna (CI) closed November 2026 at $297.00, down 0.41% for the month and +9.64% over the trailing 12 months.
- Year-to-date, CI is +7.91%, underperforming the S&P 500 which has returned +10.62% YTD.
- The stock is trading +5.03% versus its 200-day moving average ($282.77), a bullish technical signal.
- Over the past three years, CI has underperformed the S&P 500 by −70.39%, with a relative strength index reading of 58.9.
- Win rate over the trailing 39 months stands at 51.3% — 20 positive months versus 19 negative months.
Cigna ended November 2026 at $297.00, posting a monthly return of −0.41%. The S&P 500 returned −0.18% over the same window, leaving relative performance at −0.23%.
The current quarter stands at +9.26% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +5.03% versus the 200-day moving average ($282.77).
Year-to-date, CI is +7.91% against SPY +10.62%, a gap of −2.71%. The stock is currently −6.60% below its 52-week high, with maximum 3-year drawdown at −33.38%.
| Period | CI | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +0.25% | −0.36% | +0.61% |
| 1 Week | +1.16% | +2.59% | −1.43% |
| 1 Month | −0.41% | −0.18% | −0.23% |
| 3 Months | +7.87% | −2.37% | +10.24% |
| 6 Months | +0.70% | +0.83% | −0.13% |
| YTD | +7.91% | +10.62% | −2.71% |
| 12 Months | +9.64% | +12.25% | −2.61% |
| 3 Years | +0.98% | +71.37% | −70.39% |
| Rank | Month | Return |
|---|---|---|
| #1 | Dec 2023 | +13.91% |
| #2 | Nov 2025 | +13.45% |
| #3 | Aug 2025 | +12.53% |
| #4 | Feb 2024 | +11.69% |
| #5 | Oct 2026 | +9.71% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jul 2025 | −19.12% |
| #2 | Dec 2024 | −18.25% |
| #3 | Oct 2025 | −15.21% |
| #4 | Nov 2023 | −14.98% |
| #5 | Oct 2024 | −9.13% |
| Quarter | Return |
|---|---|
| Q3 2025 | −12.80% |
| Q4 2025 | −4.52% |
| Q1 2026 | −3.08% |
| Q2 2026 | +3.35% |
| Q3 2026 | −1.40% |
| Q4 2026 (QTD) | +9.26% |
| Year | Return |
|---|---|
| 2023 | −9.62% |
| 2024 | −7.78% |
| 2025 | −0.33% |
| 2026 | +7.91% |
| Metric | Value |
|---|---|
| 52-Week High | $318.00 (2026-11-05) |
| 52-Week Low | $257.86 (2026-03-30) |
| Current Price | $297.00 |
| 200-Day Moving Average | $282.77 |
| Price vs 200DMA | +5.03% |
| 3-Year Maximum Drawdown | −33.38% (2025-10-31) |
| Current Drawdown from 52W High | −6.60% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 58.9 |
| 3-Year Excess Return vs S&P 500 | −70.39% |
| RS Peak | 106.8 (May 2024) |
| RS Trough | 51.8 (Sep 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was CI's return for this report period?
CI returned −0.41% in the latest monthly window ending 2026-11-13.
Has CI outperformed SPY year to date?
YTD CI: +7.91% vs SPY: +10.62%.
What is CI's 12-month return?
+9.64% over the trailing 12 months.
Is CI above or below its 200-day moving average?
Price is +5.03% versus 200DMA ($282.77).
What is the maximum drawdown in the 3-year window?
−33.38% on 2025-10-31.